Baranick Brian 4

What Happened
Brian Baranick, EVP and GM, Precision Oncology at Exact Sciences, was granted 28,063 restricted stock units (RSUs) on February 25, 2026. The Form 4 lists this as an award/acquisition (code A) at $0.00 per unit (derivative award), meaning no cash was paid for the grant. The filing reports Mr. Baranick beneficially owns 104,669 shares of common stock and was granted an additional 28,063 RSUs.

Key Details

• Transaction date: 2026-02-25; Form filed: 2026-02-27 (filed within the typical 2‑business‑day window).
• Transaction type/code: Award/Grant (A); derivative restricted stock units reported at $0.00.
• Shares reported owned after transaction: 104,669 common shares, plus 28,063 RSUs (contingent rights). Combined potential holdings if RSUs vest: 132,732 shares.
• Footnotes: Each RSU represents a contingent right to one share (F2). The RSUs vest in four equal annual installments beginning February 25, 2027 (F3).

Context
RSUs are compensation awards that convert to shares if and when they vest; they are not an open‑market purchase or sale and do not by themselves signal buying/selling sentiment. This grant increases potential future dilution if and when the RSUs vest and the underlying shares are issued.